Read + Share
Begasse de Dhaem O, Takizawa T, Dodick DW. Long-term open-label and real-world studies of lasmiditan, ubrogepant, and
rimegepant for the acute treatment of migraine attacks. Cephalalgia 2023;43:3331024221137092.
PMID: 36739505
|
 |
|
Begasse de Dhaem O, Takizawa T, Dodick DW. Long-term open-label and real-world studies of lasmiditan, ubrogepant, and
rimegepant for the acute treatment of migraine attacks. Cephalalgia 2023;43:3331024221137092.
PMID: 36739505
|
|
|
|